THE LANCET

Respiratory Medicine

Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial

Published:January 03, 2024

Our success stories
  • Our calling is the
    fight against
    sepsis

  1. 1
  2. 2

Latest news

Our Founding History

At the dawn of the financial crisis in Greece, a group of 14 researchers and clinicians realized the need to struggle to maintain a high level of research and education for sepsis and systemic inflammation that are the main disorders leading to death in our world. This group inaugurated in July 2010 the Hellenic Institute for the Study of Sepsis (HISS), a nonprofit, non-commercial organization.

Find out how it all started

0+
scientific papers
0+
citations
0+
visits
0+
centers worldwide
0+
thesis

Linkedin news